Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Stephane Bancel

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Benzinga

Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?

Moderna stock veered higher Monday after its flu shot proved to be as effective as older technology in a final-phase study.

Investors Business Daily

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Moderna Stock Has Surged 15% This Week Despite Mixed News

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open market.

Investors Business Daily

Moderna Stock Plummets 16% After £819.59M Guidance Cut Over Respiratory Vaccine Flop

Moderna is expediting its cost-cutting program and rolling back R&D amid a drop in vaccination rates and low revenues from a new vaccine.

International Business Times UK

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Latin Times

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Moderna's CEO shares what it was like to leap from pre-revenue startup to Fortune 500 company

The COVID-19 vaccine turned Moderna into a household name. What's next for the company?

Fortune

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

The Independent UK

Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders

Moderna CEO Stephane Bancel will face off with Sen. Bernie Sanders on Wednesday over the Covid shot. The battle could rock Moderna stock.

Investors Business Daily

The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech Stocks

Startling cancer vaccine results from Moderna could drive the company's second act and usher in the next big thing in biotech. Here's what you need to know.

Investors Business Daily

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service

Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

Investors Business Daily

Moderna jab ‘to protect through the winter’ after positive new results

The main Covid-19 booster offers good protection for at least three months.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More…

Reuters

Wales Online

Full details of next Covid booster rollout -and Omicron jab will be used

The Government has confirmed who will get another Covid injection and says new vaccine will be used

The Independent UK

‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn

Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme.

Daily Record

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year.

Get all your
news in one place.

100’s of premium titles.
One news app.

Manchester Evening News

New Moderna vaccine to target two Covid strains in one dose

The UK has become the first country to approve the new booster, which is said will help protect people from Covid over the winter

The National (Scotland)

'Next generation' Covid jab approved in UK for use in adults

A new coronavirus booster jab has been approved for use in adults.

Daily Mirror

UK becomes first country to approve new Covid jab specifically targeting Omicron

Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually

Evening Standard

First Covid vaccine that targets two variants approved in UK

The ‘next generation’ Moderna jab may only need to be administered once a year

Wales Online

Once-a-year Covid jab approved for use in adults in UK

The new Moderna vaccine could put an end to three or four injections a year - and fights Omicron

The Independent UK

‘Next generation’ Moderna coronavirus booster jab approved for use in UK adults

The jab is the first to target two strains of Covid-19.

Investors Business Daily

The Good News For Moderna's Covid Shot Wasn't Good News For Its Stock

Moderna stock fell Tuesday after the company said its omicron-targeting booster generated antibodies capable of tackling new variants.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.